Novavax, Inc. : Novavax NanoFlu(TM) Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine

Go back to Novavax, Inc. : Novavax NanoFlu(TM) Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.00 --0 (-0%)
Previous Close $9.00    52 Week High $9.23 
Open $8.81    52 Week Low $1.16 
Day High $9.59    P/E N/A 
Day Low $8.81    EPS $-0.30 
Volume 4,235,734       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.00 --0 (-0%)
Previous Close $9.00    52 Week High $9.23 
Open $8.81    52 Week Low $1.16 
Day High $9.59    P/E N/A 
Day Low $8.81    EPS $-0.30 
Volume 4,235,734